Correlation Between NewAmsterdam Pharma and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and Theriva Biologics, you can compare the effects of market volatilities on NewAmsterdam Pharma and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and Theriva Biologics.
Diversification Opportunities for NewAmsterdam Pharma and Theriva Biologics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between NewAmsterdam and Theriva is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and Theriva Biologics go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and Theriva Biologics
Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 0.66 times more return on investment than Theriva Biologics. However, NewAmsterdam Pharma is 1.51 times less risky than Theriva Biologics. It trades about 0.06 of its potential returns per unit of risk. Theriva Biologics is currently generating about -0.03 per unit of risk. If you would invest 940.00 in NewAmsterdam Pharma on August 30, 2024 and sell it today you would earn a total of 1,140 from holding NewAmsterdam Pharma or generate 121.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. Theriva Biologics
Performance |
| Timeline |
| NewAmsterdam Pharma |
| Theriva Biologics |
NewAmsterdam Pharma and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and Theriva Biologics
The main advantage of trading using opposite NewAmsterdam Pharma and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| NewAmsterdam Pharma vs. Bright Minds Biosciences | NewAmsterdam Pharma vs. HP Inc | NewAmsterdam Pharma vs. Intel | NewAmsterdam Pharma vs. Chevron Corp |
| Theriva Biologics vs. Lumos Pharma | Theriva Biologics vs. Avalo Therapeutics | Theriva Biologics vs. Virpax Pharmaceuticals | Theriva Biologics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |